![]() | ||||||
| ||||||
Glucosamine Sulfate in the Treatment of Knee Osteoarthritis Symptoms: A Randomized, Double-Blind, Placebo-Controlled Study Using Acetaminophen as a Side ComparatorSource: Herrero-Beaumont G, Ivorra JAR, Trabado MDC, et al. (Arthritis & Rheumatism. 56:555-567, 2007.) ABSTRACTOBJECTIVE To assess the effects of the prescription formulation of glucosamine sulfate (1,500 mg administered once daily) on the symptoms of knee osteoarthritis (OA) during a 6-month treatment course. METHODS Three hundred eighteen patients were enrolled in this randomized, placebo-controlled, double-blind trial in which acetaminophen, the currently preferred medication for symptomatic treatment of OA, was used as a side comparator. Patients were randomly assigned to receive oral glucosamine sulfate 1,500 mg once daily (n = 106), acetaminophen 3 gm/day (n = 108), or placebo (n = 104). The primary efficacy outcome measure was the change in the Lequesne index after 6 months. Secondary parameters included the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) and response according to the Osteoarthritis Research Society International criteria. These outcome measures were assessed using an intent-to-treat analysis. RESULTS At baseline, the study patients had moderately severe OA symptoms (mean Lequesne index ~ 11 points). Glucosamine sulfate was more effective than placebo in improving the Lequesne score, with a final decrease of 3.1 points, versus 1.9 with placebo (difference -0.8 [95 % confidence interval -1.9, 0.3]) (p = 0.18). Similar results were observed for the WOMAC. There were more responders to glucosamine sulfate (39.6 %) and acetaminophen (33.3 %) than to placebo (21.2 %) (p = 0.004) and P = 0.047, respectively, versus placebo). Safely was good, and was comparable among groups. CONCLUSION The findings of this study indicate that glucosamine sulfate at the oral once-daily dosage of 1,500 mg is more effective than placebo in treating knee OA symptoms. Although acetaminophen also had a higher responder rate compared with placebo, it failed to show significant effects on the algofunctional indexes.
| ||||||
Home |
Testimonials |
How It Works |
Faq |
Contact Us |
Sitemaps Copyright 2009 TransdermalGlucosamine.com. All rights reserved. Legal Disclaimer | Terms & Conditions Information and statements on this site are provided for informational purposes only. They are not intended to diagnose, treat, cure, or prevent any disease. You should not use the information contained herein for diagnosing or treating any health problem or disease, or prescribing any medication. You should contact your doctor or medical practitioners if you you have a medical problem. You should read carefully all product packaging and labels before using them. We are not responsible or liable for any diagnosis made by a user based on the content of this website |